Treatment of varicella-zoster with cytosine arabinoside.
D000293:Adolescent; D000361:Agammaglobulinemia / Q000150:complications; D000998:Antiviral Agents; D002644:Chickenpox / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use*; D004267:DNA Viruses / Q000187:drug effects; D005260:Female; D006566:Herpesviridae Infections / Q000188:drug therapy; D014645:Herpesvirus 3, Human / Q000187:drug effects*; D006801:Humans; D007075:Immunoglobulin M / Q000627:therapeutic use; D008206:Lymphatic Diseases / Q000150:complications; D008297:Male; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D007075:Immunoglobulin M; D003561:Cytarabine